Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System

被引：12
|
作者：
Borja-Hart, Nancy L. [1 ]
Benavides, Sandra [1 ]
Christensen, Crystal [1 ]
机构：
[1] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA
来源：
ANNALS OF PHARMACOTHERAPY | 2009年 / 43卷 / 02期
关键词：
Gardasil; human papillomavirus; pediatrics; VAERS; PARTICLE VACCINE; QUADRIVALENT VACCINE; UNITED-STATES; TYPE-16; IMMUNOGENICITY; ADOLESCENTS; TRIAL; WOMEN;
D O I：
10.1345/aph.1L492
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine.
引用
收藏
页码：356 / 359
页数：4
相关论文
共 50 条
  • [31] Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Loughlin, Anita M.
    Marchant, Colin D.
    Adams, William
    Barnett, Elizabeth
    Baxter, Roger
    Black, Steve
    Casey, Christine
    Dekker, Cornelia
    Edwards, Katherine M.
    Klein, Jerold
    Klein, Nicola P.
    LaRussah, Philip
    Sparks, Robert
    Jakob, Kathleen
    VACCINE, 2012, 30 (50) : 7253 - 7259
  • [32] An Overview of Quadrivalent Human Papillomavirus Vaccine Safety 2006 to 2015
    Vichnin, Michelle
    Bonanni, Paolo
    Klein, Nicola P.
    Garland, Suzanne M.
    Block, Stan L.
    Kjaer, Susanne K.
    Sings, Heather L.
    Perez, Gonzalo
    Haupt, Richard M.
    Saah, Alfred J.
    Lievano, Fabio
    Velicer, Christine
    Drury, Rosybel
    Kuter, Barbara J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (09) : 983 - 991
  • [33] Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013
    Miller, Elaine R.
    Moro, Pedro L.
    Cano, Maria
    Lewis, Paige
    Bryant-Genevier, Marthe
    Shimabukuro, Tom T.
    VACCINE, 2016, 34 (25) : 2841 - 2846
  • [34] An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: More than intussusception alone?
    Haber, P
    Chen, RT
    Zanardi, LR
    Mootrey, GT
    English, R
    Braun, MM
    PEDIATRICS, 2004, 113 (04) : E353 - E359
  • [35] The first vaccine against cancer: the human papillomavirus vaccine
    Bosze, Peter
    ORVOSI HETILAP, 2013, 154 (16) : 603 - 618
  • [36] Human papillomavirus vaccine trials and tribulations Vaccine efficacy
    Handler, Nancy S.
    Handler, Marc Z.
    Majewski, Slawomir
    Schwartz, Robert A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (05) : 759 - 767
  • [37] Safety of quadrivalent human papillomavirus vaccine
    Omer, S. B.
    JOURNAL OF INTERNAL MEDICINE, 2012, 271 (02) : 177 - 178
  • [38] Comparative safety of two recombinant hepatitis B vaccines in children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)
    Niu, MT
    Rhodes, P
    Salive, M
    Lively, T
    Davis, DM
    Black, S
    Shinefield, H
    Chen, RT
    Ellenberg, SS
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (06) : 503 - 510
  • [39] Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011-2019
    Moro, Pedro L.
    Woo, Emily Jane
    Marquez, Paige
    Cano, Maria
    VACCINE, 2020, 38 (37) : 5923 - 5926
  • [40] Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018
    Su, John R.
    McNeil, Michael M.
    Welsh, Kerry J.
    Marquez, Paige L.
    Ng, Carmen
    Yan, Ming
    Cano, Maria, V
    VACCINE, 2021, 39 (05) : 839 - 845
12345